DK0754043T3 - Hæmning af glat muskelcelle-vandring med (R)-amlodipin - Google Patents

Hæmning af glat muskelcelle-vandring med (R)-amlodipin

Info

Publication number
DK0754043T3
DK0754043T3 DK94926189T DK94926189T DK0754043T3 DK 0754043 T3 DK0754043 T3 DK 0754043T3 DK 94926189 T DK94926189 T DK 94926189T DK 94926189 T DK94926189 T DK 94926189T DK 0754043 T3 DK0754043 T3 DK 0754043T3
Authority
DK
Denmark
Prior art keywords
pct
amlodipine
smooth muscle
cell migration
muscle cell
Prior art date
Application number
DK94926189T
Other languages
Danish (da)
English (en)
Inventor
Derek Paul Winslow
Suresh Babubhai Chahwala
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10741080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0754043(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Application granted granted Critical
Publication of DK0754043T3 publication Critical patent/DK0754043T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DK94926189T 1993-08-26 1994-08-10 Hæmning af glat muskelcelle-vandring med (R)-amlodipin DK0754043T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939317773A GB9317773D0 (en) 1993-08-26 1993-08-26 Therapeutic compound
PCT/EP1994/002697 WO1995005822A1 (en) 1993-08-26 1994-08-10 Inhibition of smooth muscle cell migration by (r)-amlodipine

Publications (1)

Publication Number Publication Date
DK0754043T3 true DK0754043T3 (da) 2000-08-07

Family

ID=10741080

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94926189T DK0754043T3 (da) 1993-08-26 1994-08-10 Hæmning af glat muskelcelle-vandring med (R)-amlodipin

Country Status (20)

Country Link
US (1) US6080761A (ko)
EP (1) EP0754043B1 (ko)
JP (2) JP3007992B2 (ko)
KR (1) KR0163840B1 (ko)
CN (1) CN1060039C (ko)
AT (1) ATE192337T1 (ko)
AU (1) AU686658B2 (ko)
CA (1) CA2170278C (ko)
DE (1) DE69424317T2 (ko)
DK (1) DK0754043T3 (ko)
ES (1) ES2145149T3 (ko)
GB (1) GB9317773D0 (ko)
GR (1) GR3033547T3 (ko)
IL (1) IL110700A (ko)
NO (1) NO308826B1 (ko)
NZ (1) NZ271993A (ko)
PT (1) PT754043E (ko)
TW (1) TW470646B (ko)
WO (1) WO1995005822A1 (ko)
ZA (1) ZA946475B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129265B2 (en) * 1999-04-23 2006-10-31 Mason R Preston Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
GB0020842D0 (en) * 2000-08-23 2000-10-11 Pfizer Ltd Therapeutic compositions
US6737430B2 (en) 2000-11-09 2004-05-18 Pfizer, Inc. Mutual prodrug of amlodipine and atorvastatin
US7335380B2 (en) 2000-12-29 2008-02-26 Synthon Ip Inc. Amlodipine free base
AT5874U1 (de) * 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
EP1345901A2 (en) * 2000-12-29 2003-09-24 Bioorganics B.V. Process for making amlodipine, derivatives thereof, and precursors therefor
CN1152013C (zh) * 2001-11-22 2004-06-02 张喜田 一类左旋氨氯地平盐的水合物及其制剂
BRPI0511095B8 (pt) * 2004-10-20 2021-05-25 Emcure Pharmaceuticals Ltd um processo para produção de enantiômero de anlodipino em alta pureza ótica
KR100828883B1 (ko) * 2006-10-27 2008-05-09 씨제이제일제당 (주) 라세믹 암로디핀으로부터 ｓ-(-)-암로디핀의 분리방법
KR100830003B1 (ko) * 2006-10-31 2008-05-15 씨제이제일제당 (주) 결정성 ｓ-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804630D0 (en) * 1988-02-27 1988-03-30 Pfizer Ltd Preparation of r-& s-amlodipine
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine

Also Published As

Publication number Publication date
DE69424317T2 (de) 2000-08-24
NO308826B1 (no) 2000-11-06
TW470646B (en) 2002-01-01
KR960703593A (ko) 1996-08-31
JP3007992B2 (ja) 2000-02-14
CA2170278A1 (en) 1995-03-02
NO960730L (no) 1996-02-23
EP0754043B1 (en) 2000-05-03
NZ271993A (en) 1997-11-24
IL110700A0 (en) 1994-11-11
GR3033547T3 (en) 2000-09-29
IL110700A (en) 1999-04-11
AU686658B2 (en) 1998-02-12
ES2145149T3 (es) 2000-07-01
ZA946475B (en) 1996-02-26
JPH08509004A (ja) 1996-09-24
US6080761A (en) 2000-06-27
ATE192337T1 (de) 2000-05-15
JP2000044475A (ja) 2000-02-15
CN1060039C (zh) 2001-01-03
PT754043E (pt) 2000-09-29
AU7612994A (en) 1995-03-21
EP0754043A1 (en) 1997-01-22
GB9317773D0 (en) 1993-10-13
KR0163840B1 (ko) 1998-12-01
CN1129907A (zh) 1996-08-28
CA2170278C (en) 1999-08-03
NO960730D0 (no) 1996-02-23
WO1995005822A1 (en) 1995-03-02
DE69424317D1 (de) 2000-06-08

Similar Documents

Publication Publication Date Title
DK0754043T3 (da) Hæmning af glat muskelcelle-vandring med (R)-amlodipin
DK0675714T3 (da) Kombination af en cholesterol-biosynteseinhibitor og en beta-lactam-cholesterolabsorptionsinhibitor
DK0754059T3 (da) Anvendelige fremgangsmåder og sammensætninger til hæmning af angiogenese
AU1694295A (en) Benzoxazinones as inhibitors of hiv reverse transcriptase
ZA969880B (en) Flame inhibitor composition and method of application
MX9304638A (es) Composicion para tratar e inhibir las ulceras gastricas y duodenales.
NO960339D0 (no) Fremgangsmåte for å inhibere restenose
NO953308D0 (no) Inhibitorer av HIV revers transkriptase
DK139093A (da) Køleanlæg og fremgangsmåde til styring af et køleanlæg
EP0651766A4 (en) INHIBITORS OF FACTOR Xa, DERIVED FROM THE INHIBITOR OF THE PANCREATIC TRYPSON FROM BEEF.
EP0671944A4 (en) TISSUE VIA-THROMBOPLASTIN FACTOR COMPLEX INHIBITORS DERIVED FROM A BOVINE PANCREATIC TRYPSIN INHIBITOR.
IS1821B (is) Samsetning 5-HT upptöku-hemils og valkvæðs 5-HT 1A -mótlyfs
DK0896544T3 (da) Kombination af en somatostatinanalog og en rapamycin
DK0773320T3 (da) Sikkerhedsark med i det væsentlige konstant tykkelse
DK0681591T3 (da) Overtrækskomposition af en hydroxyfunktionel blokcopolymerpolyester
IT1259419B (it) Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
DE69111382D1 (de) Polymerisationsinhibitor und Inhibierungsmethode für Vinylverbindungen.
EP0425909A3 (en) Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
EP0854715A4 (en) METHOD FOR INHIBITING THE PLASMINOGEN ACTIVATOR INHIBITOR
NO963469L (no) Substituert amidin-derivat og aggregasjonsblokkerer som inneholder dette
DK0722993T3 (da) Fremgangsmåde til coating af en stålplade
DE29504198U1 (de) Dehnschraube zum Korrigieren von Fehlstellungen von Zähnen
DK0950050T3 (da) Fremgangsmåde til krystallisering af et tetrahydropyridinderivat og resulterende krystalliske former
DK0728706T3 (da) Fremgangsmåde og installation til behandling af fedtet affald
DE69412460D1 (de) Verfahren zum automatischen schneiden von weichen blattmaterialien